Previous 10 | Next 10 |
Penny Stocks to Watch In September 2020 Normally, penny stocks are thought of as short-term trades. However, as we’ve come to find this year, that isn’t always the case. These cheap stocks can go on to move higher for weeks or even months. While the general tone is “capi...
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the H. C. Wainwright 22 nd Annual Global Investment Conference on Tuesday, Septe...
Sesen Bio (NASDAQ: SESN ) : Q2 GAAP EPS of -$0.24 misses by $0.15 . Cash and equivalents of $37.7M Press Release More news on: Sesen Bio, Inc., Earnings news and commentary, Healthcare stocks news, ,
On-track to complete BLA submission in the US in the fourth quarter of 2020 Entered into a license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China with $12M upfront payment Manufacturing of PPQ campaign dr...
August 5, 2020 – Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the Canaccord Genuity 40 th Annual Growth Conference on ...
3 Penny Stocks To Watch On Friday We’re at the end of another month and penny stocks are still surging. This week, the big breakout experienced by Kodak seemed to spark a rebirth in small-cap and micro-cap stocks . Now we’re seeing traders frothing at the mouth for the nex...
Sesen Bio (NASDAQ: SESN ) +22% premarket on the heels of a licensing agreement with and Qilu Pharmaceutical for the manufacture, development and commercialization of Vicineum for non-muscle invasive bladder cancer previously treated with bacillus Calmette-Guéri...
Sonnet BioTherapeutics (NASDAQ: SONN ) +118% . More news on: Sonnet BioTherapeutics Holdings, Inc., electroCore, Inc., Applied DNA Sciences, Inc., Stocks on the move, , Read more ...
Sesen to receive $12 million upfront and $23 million in potential regulatory and tech transfer milestone payments Sesen eligible to receive royalties on net sales in China Sesen to host conference call Friday, July 31 st at 8:00 a.m. EDT Sesen Bio (Nasdaq: SESN...
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that Company management will host a conference call and webcast on Friday, July 31, 2020 at 8:00 a.m. EDT to provide an Outside ...
News, Short Squeeze, Breakout and More Instantly...
Sesen Bio Inc. Company Name:
SESN Stock Symbol:
NASDAQ Market:
Declares Special Dividend in the Aggregate of $75 Million Approximately 88% Voted in Favor of the Merger at the Special Meeting Merger on Track to Close on March 7, 2023 Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today anno...
Sesen Bio Board Believes the Pending Merger with Carisma is the Most Value-Maximizing Option for Stockholders Reiterates Support from Several of Sesen Bio’s Largest Stockholders and Two Leading Independent Proxy Advisors Sesen Bio Board Unanimously Recommends All St...
Positive Recommendations Underscore that Carisma Merger Maximizes Value for Sesen Bio Stockholders Sesen Bio Board Unanimously Recommends All Stockholders to Follow ISS and Glass Lewis’s Recommendations to Vote “FOR” Value Maximizing Merger on WHITE ...